{ "items": [ "\n\n
Fegan G. et al, (2021), The Lancet. Digital health, 3
\n \n \n \n\n \n
\n \n \nEan M. et al, (2021), Wellcome open research, 6
\n \n \n \n\n \n
\n \n \nde Haan F. et al, (2021), PloS one, 16
\n \n \n \n\n \n
\n \n \nKhirikoekkong N. et al, (2020), International Health, 12, 551 - 559
\n \n \n \n\n \n
\n \n \nPLOS Medicine Staff None., (2020), PLoS medicine, 17
\n \n \n \n\n \n
\n \n \nPan-ngum W. et al, (2020)
\n \n \n \n\n \n
\n \n \nSchilling WHK. et al, (2020), Wellcome Open Research, 5, 241 - 241
\n \n \n \n\n \n
\n \n \nWhite NJ. et al, (2020), PLOS Medicine, 17, e1003252 - e1003252
\n \n \n \n\n \n
\n \n \nPratt B. et al, (2020), The American journal of bioethics : AJOB, 20, W14 - W16
\n \n \n \n\n \n
\n \n \nSwe MMM. et al, (2020), PLOS ONE, 15, e0235625 - e0235625
\n \n \n \n\n \n
\n \n \nPan-ngum W. et al, (2020), Wellcome Open Research, 5, 90 - 90
\n \n \n \n\n \n
\n \n \nPratt B. et al, (2020), The American journal of bioethics : AJOB, 20, 43 - 56
\n \n \n \n\n \n
\n \n \nvan der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
\n \n \n \n\n \n
\n \n \nPhommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190
\n \n \n \n\n \n
\n \n \nCheah PY. and Piasecki J., (2020), BMC medical ethics, 21
\n \n \n \n\n \n
\n \n \nAdhikari B. et al, (2020), Global Bioethics, 31, 1 - 12
\n \n \n \n\n \n
\n \n \nPan-Ngum W. et al, (2020), Wellcome open research, 5
\n \n \n \n\n \n
\n \n \nPan-Ngum W. et al, (2020), Wellcome open research, 5
\n \n \n \n\n \n
\n \n \nvan der Graaf R. and Cheah PY., (2019), Trials, 20
\n \n \n \n\n \n
\n \n \nRaymond M. et al, (2019), Trials, 20
\n \n \n \n\n \n
\n \n \n